OrthoXel Gains FDA Clearance for Apex Femoral Nail

OrthoXel received FDA 510(k) clearance to market the Apex Femoral Nailing System. Launch is slated for 2019. This follows the regulatory clearance and first clinical use of the company's first product, a tibial nail, in 1Q18.

The universal nail features anatomic nail curvature and can be implanted from antegrade or retrograde...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us